Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

8.3%

1 terminated/withdrawn out of 12 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

33%

4 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
4(50.0%)
Phase 4
3(37.5%)
Phase 3
1(12.5%)
8Total
N/A(4)
Phase 4(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials

All 12 trials loaded